Cutler Group LP Fulgent Genetics, Inc. Call Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$29.23 - $40.28 $102,305 - $140,980	-3,500 Reduced 97.22%	100 $0
Q3 2022 Oct 25, 2022	SELL	$37.92 - $63.74 $94,800 - $159,350	-2,500 Reduced 40.98%	3,600 $0
Q2 2022 Aug 04, 2022	SELL	$47.98 - $62.75 $148,738 - $194,525	-3,100 Reduced 33.7%	6,100 $38,000
Q1 2022 Apr 14, 2022	BUY	$49.85 - $96.11 $89,730 - $172,998	1,800 Added 24.32%	9,200 $37,000
Q4 2021 Jan 18, 2022	BUY	$77.3 - $105.0 $185,520 - $252,000	2,400 Added 48.0%	7,400 $26,000
Q3 2021 Oct 26, 2021	SELL	$74.87 - $110.87 $913,414 - $1.35 Million	-12,200 Reduced 70.93%	5,000 $45,000
Q2 2021 Jul 19, 2021	SELL	$66.8 - $100.45 $808,280 - $1.22 Million	-12,100 Reduced 41.3%	17,200 $250,000
Q1 2021 Apr 26, 2021	BUY	$59.3 - $183.85 $1.14 Million - $3.53 Million	19,200 Added 190.1%	29,300 $565,000
Q4 2020 Jan 21, 2021	BUY	$31.01 - $52.1 $260,484 - $437,640	8,400 Added 494.12%	10,100 $56,000
Q3 2020 Oct 27, 2020	BUY	$15.89 - $50.51 $27,013 - $85,867	1,700 New	1,700 $7,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.